Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exterran Holdings, Inc. (NYSE:EXH): Insiders Are Dumping, Should You?

Is Exterran Holdings, Inc. (NYSE:EXH) a buy, sell, or hold? Investors who are in the know are turning bullish. The number of long hedge fund bets inched up by 5 lately.

Exterran Holdings, Inc. (NYSE:EXH)

In the financial world, there are many indicators market participants can use to track the equity markets. A couple of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top hedge fund managers can outclass the S&P 500 by a superb amount (see just how much).

Just as key, bullish insider trading sentiment is another way to parse down the stock market universe. Obviously, there are many reasons for an upper level exec to downsize shares of his or her company, but just one, very clear reason why they would buy. Many empirical studies have demonstrated the market-beating potential of this strategy if “monkeys” understand what to do (learn more here).

Now, it’s important to take a gander at the recent action encompassing Exterran Holdings, Inc. (NYSE:EXH).

What have hedge funds been doing with Exterran Holdings, Inc. (NYSE:EXH)?

At year’s end, a total of 16 of the hedge funds we track held long positions in this stock, a change of 45% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were upping their holdings significantly.

According to our comprehensive database, Carlson Capital, managed by Clint Carlson, holds the biggest position in Exterran Holdings, Inc. (NYSE:EXH). Carlson Capital has a $78 million position in the stock, comprising 1.3% of its 13F portfolio. The second largest stake is held by Chuck Royce of Royce & Associates, with a $21 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other peers with similar optimism include SAC Subsidiary’s Sigma Capital Management, Ken Griffin’s Citadel Investment Group and Jim Simons’s Renaissance Technologies.

Consequently, specific money managers have jumped into Exterran Holdings, Inc. (NYSE:EXH) headfirst. Renaissance Technologies, managed by Jim Simons, created the largest position in Exterran Holdings, Inc. (NYSE:EXH). Renaissance Technologies had 4 million invested in the company at the end of the quarter. Glenn Russell Dubin’s Highbridge Capital Management also initiated a $2 million position during the quarter. The other funds with brand new EXH positions are John Overdeck and David Siegel’s Two Sigma Advisors, Mike Vranos’s Ellington, and Richard Driehaus’s Driehaus Capital.

How are insiders trading Exterran Holdings, Inc. (NYSE:EXH)?

Insider buying is at its handiest when the primary stock in question has seen transactions within the past six months. Over the latest six-month time frame, Exterran Holdings, Inc. (NYSE:EXH) has seen zero unique insiders buying, and 6 insider sales (see the details of insider trades here).

With the returns demonstrated by the aforementioned strategies, everyday investors should always watch hedge fund and insider trading activity, and Exterran Holdings, Inc. (NYSE:EXH) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!